OMERACT：一项旨在改善风湿病疗效评估的国际倡议。
OMERACT: an international initiative to improve outcome measurement in rheumatology.
作者信息
Tugwell Peter, Boers Maarten, Brooks Peter, Simon Lee, Strand Vibeke, Idzerda Leanne
机构信息
Department of Medicine, University of Ottawa and Institute of Population Health, Ontario, Canada.
出版信息
Trials. 2007 Nov 26;8:38. doi: 10.1186/1745-6215-8-38.
Abstract
OMERACT is the acronym for an international, informally organized network initiated in 1992 aimed at improving outcome measurement in rheumatology. Chaired by an executive committee, it organizes consensus conferences in a 2-yearly cycle that circles the globe. Data driven recommendations are prepared and updated by expert working groups. Recommendations include core sets of measures for most of the major rheumatologic conditions. Since 2002 patients have been actively engaged in the process.
摘要
OMERACT是1992年发起的一个国际非正式组织网络的首字母缩写，旨在改善风湿病的疗效评估。该组织由一个执行委员会主持，每两年在全球范围内组织一次共识会议。数据驱动的建议由专家工作组制定和更新。建议包括针对大多数主要风湿病的核心指标集。自2002年以来，患者一直积极参与这一过程。
相似文献
1
OMERACT: an international initiative to improve outcome measurement in rheumatology.
Trials. 2007 Nov 26;8:38. doi: 10.1186/1745-6215-8-38.
2
OMERACT: an international initiative to improve outcome measurement in rheumatology.
Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S10-3.
3
Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.
J Clin Epidemiol. 2014 Jul;67(7):745-53. doi: 10.1016/j.jclinepi.2013.11.013. Epub 2014 Feb 28.
4
How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.
J Rheumatol. 2014 May;41(5):1025-30. doi: 10.3899/jrheum.131314. Epub 2014 Mar 1.
5
Toward a generalized framework of core measurement areas in clinical trials: a position paper for OMERACT 11.
J Rheumatol. 2014 May;41(5):978-85. doi: 10.3899/jrheum.131307. Epub 2014 Mar 1.
6
Can we decide which outcomes should be measured in every clinical trial? A scoping review of the existing conceptual frameworks and processes to develop core outcome sets.
J Rheumatol. 2014 May;41(5):986-93. doi: 10.3899/jrheum.131308. Epub 2014 Mar 1.
7
Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group.
J Rheumatol. 2017 Dec;44(12):1916-1919. doi: 10.3899/jrheum.161105. Epub 2016 Oct 15.
8
Updating the OMERACT filter at OMERACT 11.
J Rheumatol. 2014 May;41(5):975-7. doi: 10.3899/jrheum.131306.
9
Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology.
J Rheumatol. 2019 Aug;46(8):1014-1020. doi: 10.3899/jrheum.181097. Epub 2019 Feb 15.
10
Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach.
Semin Arthritis Rheum. 2021 Jun;51(3):593-600. doi: 10.1016/j.semarthrit.2021.03.017. Epub 2021 Apr 6.
引用本文的文献
1
A core outcome set for cranioplasty following stroke or traumatic brain injury - The COAST study.
Brain Spine. 2025 Jun 1;5:104288. doi: 10.1016/j.bas.2025.104288. eCollection 2025.
2
Clinical rating scales for assessing pain in newborn infants.
Cochrane Database Syst Rev. 2025 Apr 14;4(4):MR000064. doi: 10.1002/14651858.MR000064.pub2.
3
The case for development of a core outcome set (COS) and supplemental reporting guidelines for influenza vaccine challenge trial research in swine.
Front Vet Sci. 2025 Feb 11;12:1465926. doi: 10.3389/fvets.2025.1465926. eCollection 2025.
4
Standardized uptake value-based analysis of two-phase whole-body bone tomoscintigraphies recorded with a high-speed 360° CZT camera in patients with known or suspected inflammatory arthritis.
Eur J Nucl Med Mol Imaging. 2025 Jul;52(8):2995-3003. doi: 10.1007/s00259-025-07150-0. Epub 2025 Feb 19.
5
Identifying outcome domains to establish a core outcome set for progressive pulmonary fibrosis: a scoping review.
Eur Respir Rev. 2025 Jan 22;34(175). doi: 10.1183/16000617.0133-2024. Print 2025 Jan.
6
Development of a core patient-reported outcome set for use in HIV care at the individual patient level in Montreal: protocol for a two-phased multimethod project.
BMJ Open. 2025 Jan 15;15(1):e088822. doi: 10.1136/bmjopen-2024-088822.
7
Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosis.
RMD Open. 2024 Nov 27;10(4):e004653. doi: 10.1136/rmdopen-2024-004653.
8
Assessment of validity, reliability, and feasibility of OMERACT ultrasound knee osteoarthritis scores in Egyptian patients with primary knee osteoarthritis.
Clin Rheumatol. 2024 Dec;43(12):3913-3923. doi: 10.1007/s10067-024-07171-4. Epub 2024 Oct 18.
9
Psychometric analysis and validation of the Persian translation of the systemic sclerosis questionnaire (SySQ).
J Educ Health Promot. 2024 Jul 11;13:234. doi: 10.4103/jehp.jehp_494_23. eCollection 2024.
10
A minimum data set-Core outcome set, core data elements, and core measurement set-For degenerative cervical myelopathy research (AO Spine RECODE DCM): A consensus study.
PLoS Med. 2024 Aug 22;21(8):e1004447. doi: 10.1371/journal.pmed.1004447. eCollection 2024 Aug.
本文引用的文献
1
OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction.
J Rheumatol. 1993 Mar;20(3):528-30.
Zotero 插件